In The Lancet Infectious Diseases, Ravindra Gupta and colleagues1 present alarming results on the development of pre-treatment viral resistance to the most commonly used drugs to treat HIV infection in resource-limited countries. These findings complete the bleak picture of antiretroviral (ARV) treatment failure that is gradually emerging in these countries.
Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain((R)) Line Probe Assay in Southern provinces, Zimbabwe
Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study
High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa
Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
The Southern African HIV Clinicians Society’s biannual conference, held in Johannesburg, South Africa, from 24-27 October 2018, focused on clinical content for HIV and TB health care workers in the region and featured a wide range of topics, from new antiretroviral drugs, AIDS-related complications, and opportunistic infections, to promoting adherence and ethical issues.
The Southern African HIV Clinicians Society’s biannual conference focuses on clinical content for HIV and TB health care workers. The 2018 conference programme has been carefully designed to benefit all health care practitioners, with topics ranging from new antiretroviral drugs, AIDS-related complications, opportunistic infections, promoting adherence and ethical issues.
Although great strides have been made at combating human immunodeficiency virus, leading to better quality of life and a longer life expectancy for those living with the virus, significant problems remain.
HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study
HIV drug resistance (HIVDR) poses a threat to future antiretroviral therapy success. Monitoring HIVDR patterns is of particular importance in populations such as sex workers (SWs), where documented HIV prevalence is between 34-89%, and in countries with limited therapeutic options. Currently in South Africa, there is a dearth in evidence and no ongoing surveillance of HIVDR amongst sex work populations. This study aims to describe the prevalence of HIVDR amongst a sample of female sex workers (FSWs) from Soweto, South Africa.